Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
| Image |  |
|---|---|
| Description | scientific article published on 24 June 2017 |
| Author/s |
author: Elisabet Svenungsson |
| Publication date | June 24, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |